Two Types of Macrophages: M1 and M2 Macrophages - Cusabio
CD38 expression in human M1 macrophages and analysis of the de novo NAD... | Download Scientific Diagram
CD38 and other M1 markers in macrophages treated with SASP. (A)... | Download Scientific Diagram
Discrimination of M1 and M2 macrophages via CD38 and Egr2 flow... | Download Scientific Diagram
Aging-related inflammation driven by cellular senescence enhances NAD consumption via activation of CD38+ pro-inflammatory macrophages | bioRxiv
Cells | Free Full-Text | Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma
Macrophage Immunometabolism and Inflammaging: Roles of Mitochondrial Dysfunction, Cellular Senescence, CD38, and NAD
Identification of macrophage activation-related biomarkers in obese type 2 diabetes that may be indicative of enhanced respiratory risk in COVID-19 | Scientific Reports
CD38 promotes pristane-induced chronic inflammation and increases susceptibility to experimental lupus by an apoptosis-driven and TRPM2-dependent mechanism | Scientific Reports
Frontiers | The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma | Journal for ImmunoTherapy of Cancer
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
Frontiers | Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma
Frontiers | CD38: A Significant Regulator of Macrophage Function
Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages | Nature Metabolism
Frontiers | CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity
Frontiers | CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions